Add to Calendar 11/4/2021 9:30:00 AM 11/4/2021 12:00:00 PM Digital Health Impact 2021

November 4, 2021              9:30 AM - 12 PM ET
The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities or collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients. Free virtual event
 Virtual,
CTO and Executive Vice President, Infoway
Mario Voltolina joined Infoway in 2010 and was appointed CTO and Executive Vice President in 2019. He leads a team that is identifying, assessing and measuring the impact of innovative technologies; reviewing global best practices and trends; and ensuring that Infoway and stakeholders are well-positioned to adopt the most promising digital health technology. Mario has more than 30 years of experience in the information technology industry, mainly in health care and financial services. He developed his experience with large technology companies such as Sun Microsystems and Oracle, as well as start-ups and medium sized technology firms in the fields of performance measurement and management, process control, life insurance, trading platforms and exchange systems. Mario holds a BA in International Relations from the University of Toronto.

Brought to you by